Amy W. Hudson

1.3k total citations
29 papers, 831 citations indexed

About

Amy W. Hudson is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Amy W. Hudson has authored 29 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 16 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Amy W. Hudson's work include Immune Cell Function and Interaction (15 papers), Cytomegalovirus and herpesvirus research (15 papers) and T-cell and B-cell Immunology (8 papers). Amy W. Hudson is often cited by papers focused on Immune Cell Function and Interaction (15 papers), Cytomegalovirus and herpesvirus research (15 papers) and T-cell and B-cell Immunology (8 papers). Amy W. Hudson collaborates with scholars based in United States, Lebanon and Italy. Amy W. Hudson's co-authors include Morris J. Birnbaum, Peter M. Howley, Nicole L. Glosson, Hidde L. Ploegh, Christine L. Schneider, Marı́a Luisa Ruiz, Eric M. Cooper, Joseph Amos, Joseph Wagstaff and Jenny E. Gumperz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Amy W. Hudson

29 papers receiving 822 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy W. Hudson United States 16 351 264 252 213 185 29 831
Khadija Ben-Aissa United States 9 427 1.2× 304 1.2× 82 0.3× 182 0.9× 82 0.4× 10 888
Mary Shen United States 10 578 1.6× 187 0.7× 69 0.3× 253 1.2× 103 0.6× 12 829
Laurent Vanhille France 16 732 2.1× 418 1.6× 136 0.5× 38 0.2× 146 0.8× 19 1.2k
Jacqueline K. Rainger United Kingdom 7 826 2.4× 771 2.9× 101 0.4× 139 0.7× 299 1.6× 8 1.4k
Jennifer Ashley United States 8 270 0.8× 543 2.1× 94 0.4× 106 0.5× 162 0.9× 10 1.0k
Elizabeth Radley United Kingdom 7 338 1.0× 355 1.3× 70 0.3× 81 0.4× 91 0.5× 12 658
Eva Loh Singapore 17 395 1.1× 157 0.6× 97 0.4× 343 1.6× 56 0.3× 24 795
Azadeh Bagherzadeh United Kingdom 9 557 1.6× 60 0.2× 236 0.9× 87 0.4× 152 0.8× 9 824
Normand Groulx Canada 7 634 1.8× 72 0.3× 78 0.3× 215 1.0× 89 0.5× 8 905
Toshie Shinagawa Japan 19 1.1k 3.2× 166 0.6× 70 0.3× 101 0.5× 188 1.0× 29 1.3k

Countries citing papers authored by Amy W. Hudson

Since Specialization
Citations

This map shows the geographic impact of Amy W. Hudson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy W. Hudson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy W. Hudson more than expected).

Fields of papers citing papers by Amy W. Hudson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy W. Hudson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy W. Hudson. The network helps show where Amy W. Hudson may publish in the future.

Co-authorship network of co-authors of Amy W. Hudson

This figure shows the co-authorship network connecting the top 25 collaborators of Amy W. Hudson. A scholar is included among the top collaborators of Amy W. Hudson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy W. Hudson. Amy W. Hudson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hess, Nicholas J, Sean J. McIlwain, Kalyan Nadiminti, et al.. (2023). Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology. Science Advances. 9(12). eadf0567–eadf0567. 17 indexed citations
2.
Cunsolo, Ashlee, Inez Shiwak, Michele M. Wood, et al.. (2022). “It’s like a connection between all of us”: Inuit social connections and caribou declines in Labrador, Canada. Ecology and Society. 27(4). 6 indexed citations
3.
Schneider, Christine L., et al.. (2022). Structural Models for Roseolovirus U20 And U21: Non-Classical MHC-I Like Proteins From HHV-6A, HHV-6B, and HHV-7. Frontiers in Immunology. 13. 864898–864898. 10 indexed citations
4.
Al‐Chalabi, Saif, et al.. (2022). Managing acute presentations of atheromatous renal artery stenosis. BMC Nephrology. 23(1). 210–210. 3 indexed citations
5.
Hess, Nicholas J, Elizabeth Bobeck, Shidong Ma, et al.. (2021). iNKT cells coordinate immune pathways to enable engraftment in nonconditioned hosts. Life Science Alliance. 4(7). e202000999–e202000999. 7 indexed citations
6.
Buchberger, Amanda R., et al.. (2021). The Roseoloviruses Downregulate the Protein Tyrosine Phosphatase PTPRC (CD45). Journal of Virology. 95(14). e0162820–e0162820. 9 indexed citations
7.
Hess, Nicholas J, Amy W. Hudson, Peiman Hematti, & Jenny E. Gumperz. (2020). Early T Cell Activation Metrics Predict Graft-versus-Host Disease in a Humanized Mouse Model of Hematopoietic Stem Cell Transplantation. The Journal of Immunology. 205(1). 272–281. 16 indexed citations
8.
Hess, Nicholas J, Jessica Vázquez, Amy W. Hudson, et al.. (2020). Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source. Frontiers in Immunology. 11. 573406–573406. 25 indexed citations
9.
Hudson, Amy W., et al.. (2019). HHV-7 U21 exploits Golgi quality control carriers to reroute class I MHC molecules to lysosomes. Molecular Biology of the Cell. 31(3). 196–208. 6 indexed citations
10.
Zumwalde, Nicholas A., Akshat Sharma, Shidong Ma, et al.. (2017). Adoptively transferred Vγ9Vδ2 T cells show potent antitumor effects in a preclinical B cell lymphomagenesis model. JCI Insight. 2(13). 59 indexed citations
11.
Malouli, Daniel, Scott G. Hansen, Benjamin J. Burwitz, et al.. (2016). Natural Killer Cell Evasion Is Essential for Infection by Rhesus Cytomegalovirus. PLoS Pathogens. 12(8). e1005868–e1005868. 27 indexed citations
12.
13.
Fox, Lisa, Louise Scharf, Natacha Veerapen, et al.. (2013). Expression of CD1c enhances human invariant NKT cell activation by α-GalCer.. PubMed. 13. 9–9. 11 indexed citations
14.
Schneider, Christine L. & Amy W. Hudson. (2011). The Human Herpesvirus-7 (HHV-7) U21 Immunoevasin Subverts NK-Mediated Cytoxicity through Modulation of MICA and MICB. PLoS Pathogens. 7(11). e1002362–e1002362. 42 indexed citations
15.
Glosson, Nicole L., et al.. (2010). Insight into the Mechanism of Human Herpesvirus 7 U21-mediated Diversion of Class I MHC Molecules to Lysosomes. Journal of Biological Chemistry. 285(47). 37016–37029. 15 indexed citations
16.
Glosson, Nicole L. & Amy W. Hudson. (2007). Human herpesvirus-6A and -6B encode viral immunoevasins that downregulate class I MHC molecules. Virology. 365(1). 125–135. 50 indexed citations
17.
Cooper, Eric M., Amy W. Hudson, Joseph Amos, Joseph Wagstaff, & Peter M. Howley. (2004). Biochemical Analysis of Angelman Syndrome-associated Mutations in the E3 Ubiquitin Ligase E6-associated Protein. Journal of Biological Chemistry. 279(39). 41208–41217. 87 indexed citations
18.
Hudson, Amy W., Peter M. Howley, & Hidde L. Ploegh. (2001). A Human Herpesvirus 7 Glycoprotein, U21, Diverts Major Histocompatibility Complex Class I Molecules to Lysosomes. Journal of Virology. 75(24). 12347–12358. 46 indexed citations
19.
Haffner, Christof, Kohji Takei, Hong Chen, et al.. (1997). Synaptojanin 1: localization on coated endocytic intermediates in nerve terminals and interaction of its 170 kDa isoform with Eps15. FEBS Letters. 419(2-3). 175–180. 135 indexed citations
20.
Hudson, Amy W. & Morris J. Birnbaum. (1995). Identification of a nonneuronal isoform of synaptotagmin.. Proceedings of the National Academy of Sciences. 92(13). 5895–5899. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Khadija Ben-Aissa Breakdown of academic impact, for papers by Mary Shen Breakdown of academic impact, for papers by Laurent Vanhille Breakdown of academic impact, for papers by Jacqueline K. Rainger Breakdown of academic impact, for papers by Jennifer Ashley Breakdown of academic impact, for papers by Elizabeth Radley Breakdown of academic impact, for papers by Eva Loh Breakdown of academic impact, for papers by Azadeh Bagherzadeh Breakdown of academic impact, for papers by Normand Groulx Breakdown of academic impact, for papers by Toshie Shinagawa
Rankless by CCL
2026